EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CLINICAL OUTCOMES OF COGNITIVE BEHAVIORAL THERAPY IN TREATMENT‑RESISTANT ANXIETY DISORDERS

Iqbal Afridi

Journal of Biosciences and Innovations · 30.06.2026 · 3 (01) · 63-78

DOI: 10.64037/jbi.01.37 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biosciences and Innovations, online erschienen am 30.06.2026. Verfasst von Iqbal Afridi. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A single in every six patients will not respond well to the first-line of interventions resulting in treatment-resistant anxiety disorders but no standardized definition can be used to shape future progress in understanding the most appropriate treatment plans, particularly in regard to cognitive behavioral therapy. This meta-analysis and review summarized 73 studies which investigated the impacts that CBT had on the treatment resistant forms of anxiety. Hierarchical logistic regression, random-effects meta-analysis, network meta-analysis and multivariate mixed-effects meta-regression were the steps of moderating effect of various operational definitions of treatment resistance on the effectiveness of CBT. The g of the post pre-post CBT Hedges pooled reduction of symptoms = -0.74 which reflects a moderate-large improvement but with a large degree of heterogeneity. The probability of CBT response was cut by 32% in each of the heightened previous treatments. The effect size of trials which had a 2 or higher failed adequate pharmacotherapy trials was higher than when more relaxed definitions were used. The exclusion of the pseudo-resistance factors which increased the effects sizes by 0.20 standard deviations was the best positive moderator. The multivariate model that was used accounted 64.2% of the variance in the CBT outcomes with high-intensity exposure and number of CBT sessions significant positive predictors. The network meta-analysis put CBT with SSRI at the top of the list then CBT by itself. Subgroups of diagnostics did not have any significant differences. There was low publication bias. CBT is also found to be very effective in treatment-resistant anxiety disorders as well as has equal measure to the resistance of other non-resistent populations in the absence of pseudo-resistance. Strict definition of resistance has been applied in its operations to reflect larger effects of treatment and this highlights the fact that a number of refractory cases may be due to poor previous care, as opposed to biological resistance. The high-exposure and the long-period CBT programs including pharmacotherapy are the most effective ones.

Zitieren

APA

Afridi, I. (2026). CLINICAL OUTCOMES OF COGNITIVE BEHAVIORAL THERAPY IN TREATMENT‑RESISTANT ANXIETY DISORDERS. Journal of Biosciences and Innovations, 3(01), 63-78. https://doi.org/10.64037/jbi.01.37

Vancouver

Afridi I. CLINICAL OUTCOMES OF COGNITIVE BEHAVIORAL THERAPY IN TREATMENT‑RESISTANT ANXIETY DISORDERS. Journal of Biosciences and Innovations. 2026;3(01):63-78. doi:10.64037/jbi.01.37

BibTeX
@article{Afridi2026,
  author = {Afridi, Iqbal},
  title = {CLINICAL OUTCOMES OF COGNITIVE BEHAVIORAL THERAPY IN TREATMENT‑RESISTANT ANXIETY DISORDERS},
  journal = {Journal of Biosciences and Innovations},
  year = {2026},
  volume = {3},
  number = {01},
  pages = {63--78},
  doi = {10.64037/jbi.01.37}
}
Kostenlos starten →